GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Atlantic International Corp (NAS:ATLN) » Definitions » Price-to-Free-Cash-Flow

ATLN (Atlantic International) Price-to-Free-Cash-Flow : N/A (As of May. 12, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Atlantic International Price-to-Free-Cash-Flow?

As of today (2025-05-12), Atlantic International's share price is $2.99. Atlantic International's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $-2.75. Hence, Atlantic International's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Atlantic International's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 8 years, Atlantic International's highest Price-to-Free-Cash-Flow Ratio was 1.30. The lowest was 0.29. And the median was 0.40.

ATLN's Price-to-Free-Cash-Flow is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 22.97
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Atlantic International's Free Cash Flow per Share for the three months ended in Dec. 2024 was $-0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-2.75.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 75.40% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 29.70% per year.

During the past 8 years, Atlantic International's highest 3-Year average Free Cash Flow per Share Growth Rate was 75.40% per year. The lowest was -77.00% per year. And the median was -22.20% per year.


Atlantic International Price-to-Free-Cash-Flow Historical Data

The historical data trend for Atlantic International's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atlantic International Price-to-Free-Cash-Flow Chart

Atlantic International Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - -

Atlantic International Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Atlantic International's Price-to-Free-Cash-Flow

For the Diagnostics & Research subindustry, Atlantic International's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atlantic International's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Atlantic International's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Atlantic International's Price-to-Free-Cash-Flow falls into.


;
;

Atlantic International Price-to-Free-Cash-Flow Calculation

Atlantic International's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=2.99/-2.748
=N/A

Atlantic International's Share Price of today is $2.99.
Atlantic International's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.75.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Atlantic International  (NAS:ATLN) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Atlantic International Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Atlantic International's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Atlantic International Business Description

Traded in Other Exchanges
N/A
Address
3 Federal Street, Billerica, MA, USA, 01821
Atlantic International Corp formerly SeqLL Inc is a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property across multiple omics fields. The company leverages its expertise with the True Single Molecule Sequencing platform to empower scientists and researchers with improved genetic tools to greater understand the molecular mechanisms of disease that is essential to the continued development of new breakthroughs in genomic medicine, and that hopefully address the critical concerns involved with precision medicine.
Executives
Daniel Robert Jones officer: President, CEO 317 NEW BOSTON STREET, SUITE 210, WOBURN MA 01801
Douglas Patrick Miscoll director 317 NEW BOSTON STREET, SUITE 2010, WOBURN MA 01801
David Pfeffer director 464 IVY AVENUE, HAWORTH NJ 07644
Patrice M. Milos director 317 NEW BOSTON STREET, SUITE 2010, WOBURN MA 01801
Frances P Scally officer: CHIEF FINANCIAL OFFICER 66 MELANIE LANE, SYOSSET NY 11791
John Whitcomb Kennedy officer: CFO, Secretary 166 WINN STREET, WOBURN MA 01801